تقرير تحليل حجم وحصة واتجاهات سوق عزل وتنقية الأحماض النووية في أوروبا - نظرة عامة على الصناعة وتوقعاتها حتى عام 2032

Request for TOC طلب جدول المحتويات Speak to Analyst تحدث إلى المحلل Free Sample Report تقرير عينة مجاني Inquire Before Buying استفسر قبل Buy Now اشتري الآن

تقرير تحليل حجم وحصة واتجاهات سوق عزل وتنقية الأحماض النووية في أوروبا - نظرة عامة على الصناعة وتوقعاتها حتى عام 2032

  • Healthcare
  • Published Report
  • May 2025
  • Europe
  • 350 الصفحات
  • عدد الجداول: 649
  • عدد الأرقام: 52
  • Author : Sachin Pawar

تجاوز تحديات الرسوم الجمركية من خلال استشارات سلسلة التوريد المرنة

تحليل نظام سلسلة التوريد أصبح الآن جزءًا من تقارير DBMR

Europe Nucleic Acid Isolation Purification Market

حجم السوق بالمليار دولار أمريكي

CAGR :  % Diagram

Chart Image USD 1.67 Billion USD 3.33 Billion 2024 2032
Diagram فترة التنبؤ
2025 –2032
Diagram حجم السوق (السنة الأساسية)
USD 1.67 Billion
Diagram حجم السوق (سنة التنبؤ)
USD 3.33 Billion
Diagram CAGR
%
Diagram اللاعبين الرئيسيين في الأسواق
  • Thermo Fisher Scientific Inc.
  • Illumina Inc.
  • PerkinElmer
  • Meridian Bioscience Inc.
  • QIAGEN

سوق عزل وتنقية الأحماض النووية في أوروبا، حسب المنتج (الأجهزة، والمجموعات، والكواشف)، والطريقة (العزل والتنقية باستخدام الخرز المغناطيسي، والعزل والتنقية باستخدام الأعمدة، والعزل والتنقية باستخدام الكواشف، وغيرها)، والنوع (تسلسل الجيل التالي (NGS)، وعزل وتنقية الحمض النووي الجينومي، وعزل وتنقية الحمض النووي الريبي الكلي، وتنظيف تفاعل البوليميراز المتسلسل (PCR)، وعزل وتنقية الحمض النووي البلازميدي، وعزل وتنقية الحمض النووي الريبي الرسول، وعزل وتنقية الأحماض النووية المتداولة، وعزل وتنقية الحمض النووي الريبي الدقيق، وغيرها)، والتطبيق (التشخيص، واكتشاف وتطوير الأدوية، والطب الشخصي، وأبحاث الزراعة والحيوان، وغيرها)، ونوع العينة (عينات FFPE، وخلايا الدم، والبكتيريا، والخميرة، والنباتات، والعينات الخالية من الخلايا، والخلايا المزروعة، وخلايا الثدييات، وأنسجة الدماغ والكلى، وغيرها). المستخدم النهائي (المستشفيات ومراكز التشخيص، وشركات الأدوية والتكنولوجيا الحيوية، ومنظمات البحوث التعاقدية، ومنظمات تطوير وتصنيع العقود (CDMO)، والمعاهد الأكاديمية/البحثية، وغيرها) اتجاهات الصناعة وتوقعاتها حتى عام 2032

 سوق عزل وتنقية الأحماض النووية

حجم سوق عزل وتنقية الأحماض النووية

  • بلغت قيمة سوق عزل وتنقية الأحماض النووية في أوروبا 1.67 مليار دولار أمريكي في عام 2024 ومن المتوقع أن تصل إلى 3.33 مليار دولار أمريكي بحلول عام 2032
  • خلال الفترة المتوقعة من 2025 إلى 2032، من المرجح أن ينمو السوق بمعدل نمو سنوي مركب قدره 9.6٪، مدفوعًا في المقام الأول بالإطلاق المتوقع لأجهزة العلاج الجديدة
  • ويعود هذا النمو إلى عوامل مثل الانتشار المتزايد للاضطرابات الوراثية، وخاصة في البلدان النامية، مما يدفع الطلب المتزايد على الاختبارات التشخيصية.

عزل الأحماض النووية وتحليلها وتنقيتها

  • لقد أدى الطلب المتزايد على التشخيصات القائمة على الأحماض النووية والطب الشخصي والبحث في مجال الأدوية الحيوية إلى زيادة الحاجة إلى تقنيات فعالة لعزل وتنقية الأحماض النووية.
  • بالإضافة إلى ذلك، تعمل التطورات في الأتمتة والفصل القائم على الخرز المغناطيسي والمنصات الميكروفلويدية على تعزيز سرعة وإنتاجية ودقة استخراج الأحماض النووية، ودعم التطبيقات عالية الإنتاجية في الإعدادات السريرية والبحثية.
  • على سبيل المثال، يُظهر سوق عزل الأحماض النووية وتنقيتها نموًا ملحوظًا في مناطق مثل منطقة آسيا والمحيط الهادئ، حيث تعمل قطاعات التكنولوجيا الحيوية المتوسعة وزيادة تمويل البحث والتطوير على تسريع تبني التكنولوجيا.
  • وفي الختام، فإن التقارب بين مجالات التطبيق المتنامية والابتكار المستمر في تقنيات العزل يعزز التوسع القوي في السوق، مما يتيح تحسين التشخيص الجزيئي واكتشاف الأدوية والبحث الجينومي على مستوى العالم.

نطاق التقرير وعزل الأحماض النووية وتنقيتها         

صفات

رؤى رئيسية حول سوق عزل وتنقية الأحماض النووية

القطاعات المغطاة

  • حسب المنتج : الأدوات والمجموعات والكواشف
  • حسب الطريقة : العزل والتنقية باستخدام الخرز المغناطيسي، والعزل والتنقية باستخدام العمود، والعزل والتنقية باستخدام الكواشف، وغيرها
  • حسب النوع: تسلسل الجيل التالي (NGS)، عزل وتنقية الحمض النووي الجينومي، عزل وتنقية الحمض النووي الريبي الكلي، تنظيف تفاعل البوليميراز المتسلسل (PCR)، عزل وتنقية الحمض النووي البلازميدي، عزل وتنقية الحمض النووي الريبي الرسول، عزل وتنقية الأحماض النووية المتداولة، عزل وتنقية الحمض النووي الريبي الدقيق، وغيرها
  • حسب التطبيق : التشخيص، واكتشاف الأدوية وتطويرها، والطب الشخصي، والبحوث الزراعية والحيوانية، وغيرها
  • حسب نوع العينة : عينات FFPE، وخلايا الدم، والبكتيريا، والخميرة، والنباتات، والعينات الخالية من الخلايا، والخلايا المزروعة، وخلايا الثدييات، وأنسجة المخ والكلى، وغيرها
  • من قبل المستخدم النهائي : المستشفيات ومراكز التشخيص، وشركات الأدوية والتكنولوجيا الحيوية، ومنظمات أبحاث العقود، ومنظمة تطوير وتصنيع العقود: CDMO)، والمعاهد الأكاديمية/البحثية، وغيرها

الدول المغطاة

أوروبا

  • ألمانيا
  • المملكة المتحدة
  • فرنسا
  • إيطاليا
  • إسبانيا
  • سويسرا
  • روسيا
  • ديك رومى
  • بلجيكا
  • هولندا
  • الدنمارك
  • بولندا
  • السويد
  • النرويج
  • فنلندا
  • بقية أوروبا

اللاعبون الرئيسيون في السوق

  • شركة ثيرمو فيشر العلمية (الولايات المتحدة)
  • شركة إيلومينا (الولايات المتحدة)
  • بيركين إلمر (الولايات المتحدة)
  • شركة ميريديان للعلوم البيولوجية (الولايات المتحدة)
  • كياجن (ألمانيا)
  • شركة تاكارا بيو (اليابان)
  • شركة ماشري ناجل المحدودة وشركاه (ألمانيا)
  • شركة ليبو للتكنولوجيا الطبية (بكين) المحدودة (الصين)
  • ميرك كي جي ايه (ألمانيا)
  • سيتيفا (شركة داناهر) (الولايات المتحدة)
  • شركة أجيلنت تكنولوجيز (الولايات المتحدة)
  • مختبرات بيو-راد، المحدودة (الولايات المتحدة)
  • شركة إف. هوفمان-لا روش المحدودة (سويسرا)
  • شركة كورابو للصناعات المحدودة (اليابان)
  • شركة أوميغا بايو تيك (الولايات المتحدة)
  • شركة زيمو للأبحاث (الولايات المتحدة)
  • أناليتيك جينا GmbH+Co. كغ (ألمانيا)
  • LGC Biosearch Technologies (المملكة المتحدة)
  • شركة دان جين المحدودة (الصين)
  • شركة ماج جينوم تكنولوجيز المحدودة (الهند)
  • تيانجين للتكنولوجيا الحيوية (بكين) المحدودة. (الصين)
  • شركة بروميجا (الولايات المتحدة)
  • مختبرات نيو إنجلاند البيولوجية (الولايات المتحدة)
  • شركة كورابو للصناعات المحدودة (اليابان)
  • شركة أوميجا بايو تيك (الولايات المتحدة)
  • شركة زيمو للأبحاث (الولايات المتحدة)
  • أناليتيك جينا GmbH+Co. كغ (ألمانيا)
  • شركة دان جين المحدودة (الصين)
  • شركة ماج جينوم تكنولوجيز المحدودة (الهند)
  • تيانجين للتكنولوجيا الحيوية (بكين) المحدودة. (الصين)

فرص السوق

  • ارتفاع في التقدم التكنولوجي والأتمتة
  • تزايد اعتماد تسلسل الجيل التالي (NGS)

مجموعات معلومات البيانات ذات القيمة المضافة

بالإضافة إلى الرؤى حول سيناريوهات السوق مثل القيمة السوقية ومعدل النمو والتجزئة والتغطية الجغرافية واللاعبين الرئيسيين، تتضمن تقارير السوق التي تم تنظيمها بواسطة Data Bridge Market Research أيضًا تحليل الاستيراد والتصدير، ونظرة عامة على القدرة الإنتاجية، وتحليل استهلاك الإنتاج، وتحليل اتجاه الأسعار، وسيناريو تغير المناخ، وتحليل سلسلة التوريد، وتحليل سلسلة القيمة، ونظرة عامة على المواد الخام / المواد الاستهلاكية، ومعايير اختيار البائعين، وتحليل PESTLE، وتحليل بورتر، والإطار التنظيمي.

اتجاهات سوق عزل وتنقية الأحماض النووية

"التطبيقات المتنامية لخزعة السائل في التشخيص غير الجراحي"

  • تتيح الخزعة السائلة، التي تحلل الأحماض النووية المتداولة (DNA، RNA، الإكسوسومات) في سوائل الجسم مثل الدم، الكشف المبكر عن الأمراض المختلفة ومراقبتها وعلاجها بشكل شخصي، وخاصة السرطان.
  • تتطلب عملية استخراج الأحماض النووية عالية الجودة من هذه العينات المتنوعة والمجزأة في كثير من الأحيان تقنيات عزل وتنقية متقدمة   
  • على سبيل المثال ، تُحدث خزعة السوائل، جنبًا إلى جنب مع تقنيات الجينوم عالية الإنتاجية، نقلة نوعية في إدارة الأمراض من خلال تشخيصات شخصية وغير جراحية. يُبرز توسيع نطاق استخدامها عبر مختلف السوائل الحيوية ودمجها في الممارسة السريرية فائدتها المتزايدة. يُسهم التوحيد القياسي، وتحسين البروتوكولات، واكتشاف المؤشرات الحيوية في دفع عجلة التقدم في مجال تنقية الأحماض النووية، مما يُتيح رعايةً أكثر دقةً وسهولةً وخصوصيةً للمرضى.
  • إن ظهور الخزعة السائلة كأداة تشخيصية غير جراحية يوفر فرصًا كبيرة لسوق عزل وتنقية الأحماض النووية.
  • مع تزايد استخدام الخزعة السائلة للكشف المبكر عن الأمراض ومراقبة العلاج، هناك حاجة متزايدة إلى تقنيات تنقية متقدمة قادرة على استخراج الأحماض النووية عالية الجودة من السوائل البيولوجية المعقدة.

ديناميكيات سوق عزل وتنقية الأحماض النووية

سائق

"الاستثمار المتزايد في أبحاث الجينوم"

  • لقد أدى تدفق التمويل من الحكومات والقطاع الخاص ومؤسسات البحث في جميع أنحاء العالم إلى تكثيف الحاجة إلى عزل الأحماض النووية بشكل موثوق وعالي الجودة لدعم مشاريع التسلسل واسعة النطاق، وتحرير الجينات، واكتشاف المؤشرات الحيوية، ومبادرات الطب الشخصي.
  • يعزز هذا الاستثمار الطلب على أنظمة تنقية فعالة ودقيقة تضمن أن عينات الحمض النووي والحمض النووي الريبي تلبي الجودة المطلوبة للتطبيقات المتقدمة مثل CRISPR وتسلسل الجيل التالي (NGS) وأدوات الجينوم الأخرى
  • مع توسع الأبحاث، تتزايد الحاجة إلى طرق عزل قابلة للتطوير وعالية الإنتاجية، مما يعزز نمو السوق ويدفع الابتكار في تقنيات تنقية الأحماض النووية.

على سبيل المثال،

  • في ديسمبر 2022، ووفقًا للمجلة الطبية البريطانية، كانت الحكومة تخطط لاستثمار أكثر من 190.54 مليون دولار أمريكي في تحسين تشخيص الأمراض الوراثية النادرة لدى حديثي الولادة، وتحسين تشخيص السرطان، ومعالجة التفاوتات الصحية، وذلك ضمن خطتها الممتدة لثلاث سنوات. ومع ازدياد الاستثمار، تظهر ابتكارات جديدة في هذا المجال تُسهم في نمو السوق.
  • في سبتمبر 2023، ووفقًا للمعهد الوطني لأبحاث الجينوم البشري (NHGRI)، سيعمل المعهد على تسريع أبحاث الجينوم من خلال تمويل العلماء والتعاون معهم في المؤسسات الحكومية والعامة والخاصة. ومن خلال مبادرات مثل برنامج أبحاثنا جميعًا ومبادرة ENCODE، يدعم المعهد الوطني لأبحاث الجينوم البشري (NHGRI) الأبحاث المتعلقة بالاختلافات الجينية وتأثيرها على الصحة. وتمتد الشراكات لتشمل التطورات التكنولوجية في مجال التسلسل وتحليل البيانات، مما يُحسّن الأدوات الجينومية وتبادل المعرفة. ويهدف هذا النهج التعاوني إلى تحقيق إنجازات في الطب الدقيق والصحة العامة.
  • إن زيادة الاستثمار في أبحاث الجينوم تعمل على تعزيز سوق عزل وتنقية الأحماض النووية، حيث يدعم المزيد من التمويل الدراسات الجينية المتقدمة وتطوير العلاجات المستهدفة
  • يتزايد هذا الطلب على تنقية الحمض النووي والحمض النووي الريبي عالي الجودة مع التطبيقات الموسعة مثل NGS وCRISPR، مما يخلق الحاجة إلى حلول عزل فعالة وقابلة للتطوير لدعم علم الجينوم المتطور.

فرصة

"التطورات التكنولوجية والأتمتة"

  • تعمل الابتكارات التكنولوجية مثل أنظمة الاستخراج الآلية بالكامل، والتسلسل عالي الإنتاجية، والميكروفلويديك على تعزيز الدقة والسرعة وقابلية التوسع في البحث الجيني والتشخيص
  • من خلال تقليل التدخل اليدوي، تُقلل هذه التطورات من الأخطاء البشرية وتُحسّن من اتساق معالجة العينات. كما تُلبي الطلب المتزايد في مجال الجينوميات والبروتينات والطب الشخصي، من خلال تمكين المختبرات من معالجة كميات أكبر من العينات بدقة وكفاءة.

على سبيل المثال،

  • في ديسمبر 2023، ووفقًا لشبكات التكنولوجيا، أطلقت شركة Thermo Fisher Scientific Inc.، الرائدة عالميًا في مجال الخدمات العلمية، جهاز Thermo Scientific KingFisher Apex Dx، وهو جهاز آلي لتنقية الأحماض النووية، بالإضافة إلى طقم عزل الفيروسات/مسببات الأمراض MagMAX Dx من Applied Biosystems. يعمل هذان المنتجان معًا لتمكين عزل وتنقية مسببات الأمراض الفيروسية والبكتيرية من عينات الجهاز التنفسي. صُممت هذه الحلول الآلية لتتوافق مع معايير التشخيص المخبري (IVD) ولوائح التشخيص المخبري (IVD-R)، مما يوفر للمختبرات موثوقية عالية لنتائج الاختبارات اللاحقة.
  • في نوفمبر 2023، أشارت شركة إلسفير إلى أن تطوير أجهزة استخلاص وتنقية الحمض النووي الريبوزي/الحمض النووي الريبوزي (RNA/DNA) الآلية لتشخيص الأمراض المعدية يُمثل تقدمًا محوريًا في التكنولوجيا الحيوية، مُبرزًا بذلك تنامي الابتكارات التكنولوجية والأتمتة في هذا المجال. تُبسط هذه الأجهزة سير العمل المُعقد في المختبرات، مما يُتيح معالجة سريعة ودقيقة للعينات، وهو أمر بالغ الأهمية للتشخيص الدقيق، لا سيما أثناء تفشي الأمراض. وقد أدى التقدم التكنولوجي إلى أنظمة أكثر إحكامًا وكفاءة وسهولة في الاستخدام، مما يُقلل التدخل اليدوي ويُعزز الإنتاجية والموثوقية. لا تُقلل الأتمتة من الأخطاء فحسب، بل تُزيد أيضًا من سرعة عمليات التشخيص، مما يدعم اتخاذ القرارات السريرية في الوقت المناسب ويُحسّن نتائج المرضى. يُحدث دمج هذه التقنيات المتقدمة تحولًا في التشخيص، ويجعله أكثر سهولة في الوصول إليه وقابلية للتطوير والتكيف مع مختلف بيئات الرعاية الصحية.
  • إن التطورات السريعة في التكنولوجيا والأتمتة تعمل على تحويل سوق عزل وتنقية الأحماض النووية من خلال تعزيز الدقة والكفاءة والتكامل مع العمليات اللاحقة
  • تُمكّن هذه الابتكارات المختبرات من تلبية الطلب المتزايد في مجالات الجينوم والتشخيص والطب الشخصي بإنتاجية أعلى وتكاليف أقل. ومع اتساع نطاق الوصول إلى هذه التقنيات، فإنها تُوسّع نطاق قدرات البحث والتشخيص، مما يُعزز اعتمادها على نطاق أوسع في المختبرات والمؤسسات حول العالم، ويساهم في نهاية المطاف في تسريع التقدم في العديد من المجالات العلمية والطبية.

ضبط النفس/التحدي

"الصعوبات التقنية في عزل الأحماض النووية عبر أنواع مختلفة من العينات"

  • تشكل مصادر العينات المختلفة، مثل الدم والأنسجة والبول واللعاب، تحديات فريدة بسبب المستويات المختلفة لتركيزات الأحماض النووية، ووجود مثبطات، وتعقيد المصفوفة البيولوجية
  • قد تحتوي عينات الدم على كميات قليلة من الحمض النووي أو الحمض النووي الريبي الحر المتداول، في حين أن عينات الأنسجة قد تكون أكثر تحديًا بسبب المستويات العالية من الملوثات والمكونات الخلوية التي تتداخل مع استخراج الأحماض النووية.
  • كما تتطلب عينات معينة، مثل تلك المأخوذة من الأنسجة المثبتة بالفورمالين والمغموسة بالبارافين، أساليب متخصصة لمنع تحلل الأحماض النووية أو فقدانها أثناء عملية العزل.

على سبيل المثال،

  • في سبتمبر 2020، ذكرت مقالة نشرتها APOS أن العينات البيولوجية، مثل اللعاب أو البول، تحتوي على تركيزات منخفضة من الأحماض النووية، مما يتطلب بروتوكولات دقيقة للغاية لضمان دقة الاستخلاص. غالبًا ما تُشكل الأنسجة، وخاصةً تلك التي تحتوي على مستويات عالية من البروتينات أو الدهون، عقبات في فصل الأحماض النووية النقية دون تلوث. كما تخضع عينات مثل أنسجة FFPE لتثبيت الفورمالين، مما يؤدي إلى تشابك الأحماض النووية ويزيد من صعوبة الاستخلاص. ومع ذلك، يظل التغلب على التعقيدات الكامنة في أنواع العينات المختلفة محورًا أساسيًا للتطورات المستقبلية، مما يضمن أن تكون طرق استخلاص وعزل الأحماض النووية قابلة للتكيف وفعالة وقابلة للتطوير لمجموعة واسعة من التطبيقات السريرية والبحثية.
  • في سبتمبر 2020، وكما هو موضح في "مصفوفات العينات المعقدة"، غالبًا ما تحتوي على مثبطات تتداخل مع تضخيم الأحماض النووية، مما يقلل من حساسية الاختبار وموثوقيته. يجب أن تتجنب طرق التحليل والاستخلاص الفعالة هذه المثبطات مع الحفاظ على التوافق مع سير العمل المبسط. يُعدّ تحقيق التوازن بين الأداء وسهولة النقل أمرًا أساسيًا لتكييف عمليات تنقية الأحماض النووية مع منصات التشخيص الميدانية الجاهزة للاستخدام عند الحاجة.
  • إن التحديات التقنية في عزل الأحماض النووية من أنواع مختلفة من العينات، مثل الدم والأنسجة والبول، تخلق عقبات في سوق تنقية الأحماض النووية
  • غالبًا ما تقدم هذه العينات إنتاجًا منخفضًا من الأحماض النووية، أو مثبطات، أو مصفوفات بيولوجية معقدة، مما يتطلب طرقًا متخصصة لاستخراج فعال

نطاق سوق عزل وتنقية الأحماض النووية في أوروبا

يتم تصنيف سوق عزل وتنقية الأحماض النووية في أوروبا إلى خمسة قطاعات بارزة على أساس المنتج والطريقة والنوع ونوع العينة والمستخدم النهائي.

التجزئة

التجزئة الفرعية

حسب المنتج

  • الآلات الموسيقية
  • يكتب
    • المجانس
    •  أجهزة قياس الطيف الضوئي
    •  أجهزة قياس الفلورسنت
    •  آحرون
  • النمط
    •  سطح المنضدة
    •  مستقل
  • قابلية الاستخدام
    •  آلي
    •  يدوي
  • مجموعات
    •  مجموعات عزل وتنقية الحمض النووي
      • مجموعة تعتمد على الخرز المغناطيسي
        •  مجموعة عزل الأحماض النووية للفيروسات/المسببات المرضية
        •  مجموعة عزل الحمض النووي للنبات
        •  مجموعة الأحماض النووية الكلية الخالية من الخلايا
        •  مجموعة عزل الحمض النووي الخالي من الخلايا
      • مجموعة تعتمد على الأعمدة
        •  مجموعة تنقية الحمض النووي الجينومي
        •  مجموعة تنقية الحمض النووي الريبي/الحمض النووي الفيروسي
        •  مجموعة تنقية الحمض النووي للنباتات
        •  مجموعة تنقية الحمض النووي للميكروبيوم
        •  آحرون
      • مجموعة تعتمد على الكواشف
    •  مجموعات عزل وتنقية الحمض النووي الريبي
      • مجموعة تعتمد على الخرز المغناطيسي
        • مجموعة عزل الأحماض النووية الفيروسية/الممرضة
        • مجموعة تنقية mRNA
        • مجموعة عزل الحمض النووي الريبوزي النباتي
        • مجموعة عزل الأحماض النووية الخالية من الخلايا
        • آحرون
      • مجموعة تعتمد على الأعمدة
        • مجموعة عزل الحمض النووي الريبي
        • مجموعة عزل Mi RNA
        • مجموعة الحمض النووي الريبي/الحمض النووي الفيروسي
      • مجموعة تعتمد على الكواشف
    •  مجموعات عزل الأحماض النووية الفيروسية
      • مجموعات تعتمد على الخرز المغناطيسي
      • مجموعات عمود الدوران الفيروسي
    •  مجموعة تنقية البلازميد
    •  مجموعة PCR وGel
    •  آحرون
  •  الكواشف
    • كاشف عزل الحمض النووي
    • كاشف عزل الحمض النووي الريبي
    • آحرون

حسب الطريقة

  • العزل والتنقية باستخدام الخرز المغناطيسي
  • العزل والتنقية القائمة على العمود
  • العزل والتنقية القائمة على الكواشف
  • آحرون

حسب النوع

  • التشخيص
    •  الآلات الموسيقية
    •  مجموعات
    •  الكواشف
  •  اكتشاف الأدوية وتطويرها
    •  الآلات الموسيقية
    •  مجموعات
    •  الكواشف
  •  الطب الشخصي
    •  الآلات الموسيقية
    •  مجموعات
    •  الكواشف
  •  البحوث الزراعية والحيوانية
    •  الآلات الموسيقية
    •  مجموعات
    •  الكواشف
  •  آخر

حسب نوع العينة

  • عينات FFPE
  •  خلايا الدم
  •  البكتيريا والخميرة والنباتات
  •  عينات خالية من الخلايا
  •  الخلايا المزروعة
  •  الخلايا الثديية
  •  أنسجة المخ والكلى
  •  آحرون

حسب المستخدم النهائي

  • المستشفيات ومراكز التشخيص
  • شركات الأدوية والتكنولوجيا الحيوية
  • منظمات البحوث التعاقدية
  • منظمة تطوير العقود والتصنيع (CDMO)
  • المعاهد الأكاديمية/البحثية
  • آحرون

تحليل إقليمي لسوق عزل وتنقية الأحماض النووية في أوروبا

"ألمانيا هي الدولة المهيمنة في سوق عزل وتنقية الأحماض النووية"

  • ألمانيا هي المنطقة المهيمنة في سوق عزل وتنقية الأحماض النووية بسبب قطاعات التكنولوجيا الحيوية والأدوية القوية، بدعم من البنية التحتية القوية للبحث والتطوير
  •  علاوة على ذلك، فإن وجود كبار اللاعبين في السوق ومؤسسات البحث في ألمانيا يعزز الابتكار والتقدم في تقنيات عزل وتنقية الأحماض النووية.
  • بالإضافة إلى ذلك، يساهم الاستثمار المرتفع في البحث الجينومي والطب الدقيق في زيادة الطلب على حلول متقدمة لاستخراج وتنقية الأحماض النووية في ألمانيا.

من المتوقع أن تسجل ألمانيا أعلى معدل نمو سنوي مركب في السوق

  • من المتوقع أن تسجل ألمانيا نموًا قويًا في سوق عزل وتنقية الأحماض النووية، مدفوعًا بالاستثمارات المتزايدة في أبحاث التكنولوجيا الحيوية وعلوم الحياة.
  •  علاوة على ذلك، يُسهم تزايد اعتماد الطب الشخصي في ألمانيا، إلى جانب الطلب المتزايد على التشخيص الجزيئي، بشكل كبير في توسع السوق. كما أن الطفرة في أنشطة البحث الأكاديمي والسريري، وخاصةً في مجال الجينوميات والطب الدقيق، تُعزز الحاجة إلى تقنيات متقدمة لعزل وتنقية الأحماض النووية في ألمانيا.
  • بالإضافة إلى ذلك، من المتوقع أن يؤدي وجود الشركات الناشئة في مجال التكنولوجيا الحيوية والتعاون مع شركات الأدوية الراسخة إلى تعزيز المزيد من النمو والابتكار في سوق عزل وتنقية الأحماض النووية في ألمانيا.

حصة سوق عزل وتنقية الأحماض النووية

يُقدم المشهد التنافسي في السوق تفاصيل لكل منافس. تشمل هذه التفاصيل لمحة عامة عن الشركة، وبياناتها المالية، وإيراداتها المحققة، وإمكانياتها السوقية، والاستثمار في البحث والتطوير، ومبادراتها السوقية الجديدة، وحضورها في أوروبا، ومواقع ومرافق الإنتاج، وقدراتها الإنتاجية، ونقاط قوتها وضعفها، وإطلاق المنتجات، ونطاقها، وهيمنة تطبيقاتها. تتعلق البيانات المذكورة أعلاه فقط بتركيز الشركات على السوق.

الشركات الرائدة الرئيسية العاملة في السوق هي:

  • شركة ثيرمو فيشر العلمية (الولايات المتحدة)
  • شركة إيلومينا (الولايات المتحدة)
  • بيركين إلمر (الولايات المتحدة)
  • شركة ميريديان للعلوم البيولوجية (الولايات المتحدة)
  • كياجن (ألمانيا)
  • شركة تاكارا بيو (اليابان)
  • شركة ماشري ناجل المحدودة وشركاه (ألمانيا)
  • شركة ليبو للتكنولوجيا الطبية (بكين) المحدودة (الصين)
  • ميرك كي جي ايه (ألمانيا)
  • سيتيفا (شركة داناهر) (الولايات المتحدة)
  • شركة أجيلنت تكنولوجيز (الولايات المتحدة)
  • مختبرات بيو-راد، المحدودة (الولايات المتحدة)
  • شركة إف. هوفمان-لا روش المحدودة (سويسرا)
  • شركة كورابو للصناعات المحدودة (اليابان)
  • شركة أوميغا بايو تيك (الولايات المتحدة)
  • شركة زيمو للأبحاث (الولايات المتحدة)
  • أناليتيك جينا GmbH+Co. كغ (ألمانيا)
  • LGC Biosearch Technologies (المملكة المتحدة)
  • شركة دان جين المحدودة (الصين)
  • شركة ماج جينوم تكنولوجيز المحدودة (الهند)
  • تيانجين للتكنولوجيا الحيوية (بكين) المحدودة. (الصين)
  • شركة بروميجا (الولايات المتحدة)
  • مختبرات نيو إنجلاند البيولوجية (الولايات المتحدة)
  • شركة كورابو للصناعات المحدودة (اليابان)
  • شركة أوميجا بايو تيك (الولايات المتحدة)
  • شركة زيمو للأبحاث (الولايات المتحدة)
  • أناليتيك جينا GmbH+Co. كغ (ألمانيا)
  • شركة دان جين المحدودة (الصين)
  • شركة ماج جينوم تكنولوجيز المحدودة (الهند)
  • تيانجين للتكنولوجيا الحيوية (بكين) المحدودة. (الصين)

أحدث التطورات في عزل وتنقية الأحماض النووية

  • في أبريل 2025، طرحت شركة Analytik Jena صينيةً جديدةً مزودةً بـ 1536 طرفًا لجهاز CyBio Well vario، مما يتيح سحب العينات بالتوازي عبر 1536 قناةً بأحجام تتراوح بين 100 نانولتر و8 ميكرولتر. هذا الابتكار، المثالي للتطبيقات عالية الإنتاجية، يضمن دقةً عاليةً واستهلاكًا منخفضًا للكواشف، ويدعم سير عملٍ مختبريٍّ مستدامٍ وقابلٍ للتكرار.
  • في مارس 2024، أطلقت شركة Analytik Jena سلسلة أجهزة تحليل TOC/TNb متعددة N/C x300، التي تتميز بتصميم سهل الاستخدام، وأتمتة مرنة، وبرمجيات بديهية. هذه الأجهزة مثالية للتطبيقات البيئية والصيدلانية، وتضمن إنتاجية عالية، وموثوقية، وتكاليف تشغيل منخفضة، مما يتيح تحضير العينات ومعايرتها وصيانتها بكفاءة مع الحفاظ على سلامة البيانات المتوافقة مع معايير الأدوية. 


SKU-

احصل على إمكانية الوصول عبر الإنترنت إلى التقرير الخاص بأول سحابة استخبارات سوقية في العالم

  • لوحة معلومات تحليل البيانات التفاعلية
  • لوحة معلومات تحليل الشركة للفرص ذات إمكانات النمو العالية
  • إمكانية وصول محلل الأبحاث للتخصيص والاستعلامات
  • تحليل المنافسين باستخدام لوحة معلومات تفاعلية
  • آخر الأخبار والتحديثات وتحليل الاتجاهات
  • استغل قوة تحليل المعايير لتتبع المنافسين بشكل شامل
طلب التجريبي

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET

1.4 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.8 DBMR MARKET POSITION GRID

2.9 VENDOR SHARE ANALYSIS

2.1 MARKET END USER COVERAGE GRID

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHT

4.1 PORTER’S FIVE FORCES

4.2 PESTEL ANALYSIS

4.3 DEFINITION AND IMPORTANCE OF TARIFFS IN THE HEALTHCARE SECTOR

5 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: REGULATIONS

5.1 REGULATORY AUTHORITIES IN THE ASIA-PACIFIC REGION

5.2 NORTH AMERICA REGULATORY SCENARIO

5.3 EUROPE REGULATORY SCENARIO

5.4 REGULATORY SUBMISSIONS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING PREVALENCE OF GENETIC DISORDERS

6.1.2 INCREASING DEMAND FOR DIAGNOSTIC TESTING

6.1.3 RISING INVESTMENT IN GENOMICS RESEARCH

6.1.4 INCREASE IN LAUNCH OF DIAGNOSTIC PRODUCTS

6.2 RESTRAINTS

6.2.1 RISKS ASSOCIATED WITH SAMPLE CONTAMINATION

6.2.2 HIGH COST OF EQUIPMENT AND REAGENTS

6.3 OPPORTUNITIES

6.3.1 RISE IN TECHNOLOGICAL ADVANCEMENTS AND AUTOMATION

6.3.2 INCREASING ADOPTION OF NEXT-GENERATION SEQUENCING (NGS)

6.3.3 GROWING APPLICATIONS OF LIQUID BIOPSY IN NON-INVASIVE DIAGNOSTICS

6.4 CHALLENGES

6.4.1 TECHNICAL DIFFICULTIES IN NUCLEIC ACID ISOLATION ACROSS DIFFERENT SAMPLE TYPES

6.4.2 ENVIRONMENTAL AND SUSTAINABILITY CONCERNS

7 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE

7.1 OVERVIEW

7.2 NEXT GENERATION SEQUENCING (NGS)

7.3 GENOMIC DNA ISOLATION AND PURIFICATION

7.4 TOTAL RNA ISOLATION AND PURIFICATION

7.5 PCR CLEAN-UP

7.6 PLASMID DNA ISOLATION AND PURIFICATION

7.7 MESSENGER RNA ISOLATION AND PURIFICATION

7.8 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION

7.9 MICRORNA ISOLATION AND PURIFICATION

7.1 OTHERS

8 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT

8.1 OVERVIEW

8.2 INSTRUMENTS

8.2.1 HOMOGENIZER

8.2.2 SPECTROPHOTOMETERS

8.2.3 FLUOROMETERS

8.2.4 OTHERS

8.2.4.1 Benchtop

8.2.4.2 Standalone

8.2.4.2.1 Automated

8.2.4.2.2 Manual

8.3 KITS

8.3.1 DNA ISOLATION & PURIFICATION KITS

8.3.2 RNA ISOLATION & PURIFICATION KITS

8.3.3 VIRAL NUCLEIC ACID ISOLATION KITS

8.3.4 PLASMID PURIFICATION KIT

8.3.5 PCR AND GEL KIT

8.3.6 OTHERS

8.3.6.1 MAGNETIC BEAD-BASED KIT

8.3.6.2 COLUMN-BASED KIT

8.3.6.3 REAGENT-BASED KIT

8.3.6.3.1 VIRAL/PATHOGEN NUCLEIC ACID ISOLATION KIT

8.3.6.3.2 PLANT DNA ISOLATION KIT

8.3.6.3.3 CELL-FREE TOTAL NUCLEIC ACID KIT

8.3.6.3.4 CELL-FREE DNA ISOLATION KIT

8.3.7 GENOMIC DNA PURIFICATION KIT

8.3.8 VIRAL RNA/DNA PURIFICATION KIT

8.3.9 PLANT DNA PURIFICATION KIT

8.3.10 MICROBIOME DNA PURIFICATION KIT

8.3.11 OTHERS

8.3.12 MAGNETIC BEAD-BASED KIT

8.3.13 COLUMN-BASED KIT

8.3.14 REAGENT-BASED KIT

8.3.15 VIRAL/PATHOGEN NUCLEIC ACID ISOLATION KIT

8.3.16 MRNA PURIFICATION KIT

8.3.17 PLANT RNA ISOLATION KIT

8.3.18 CELL-FREE NUCLEIC ACID ISOLATION KIT

8.3.19 OTHERS

8.3.20 RNA ISOLATION KIT

8.3.21 MI RNA ISOLATION KIT

8.3.22 VIRAL RNA/DNA KIT

8.3.23 MAGNETIC BEAD-BASED KITS

8.3.24 VIRAL SPIN-COLUMN KITS

8.4 REAGENTS

8.4.1 DNA ISOLATION REAGENT

8.4.2 RNA ISOLATION REAGENT

8.4.3 OTHERS

9 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE

9.1 OVERVIEW

9.2 FFPE SAMPLES

9.3 BLOOD CELLS

9.4 BACTERIA, YEAST, AND PLANTS

9.5 CELL-FREE SAMPLES

9.6 CULTURED CELLS

9.7 MAMMALIAN CELLS

9.8 BRAIN AND KIDNEY TISSUE

9.9 OTHERS

10 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD

10.1 OVERVIEW

10.2 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION

10.3 COLUMN -BASED ISOLATION AND PURIFICATION

10.4 REAGENT-BASED ISOLATION AND PURIFICATION

10.5 OTHERS

11 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION

11.1 OVERVIEW

11.2 DIAGNOSTICS

11.2.1 INSTRUMENTS

11.2.2 KITS

11.2.3 REAGENTS

11.3 DRUG DISCOVERY AND DEVELOPMENT

11.3.1 INSTRUMENTS

11.3.2 KITS

11.3.3 REAGENTS

11.4 PERSONALIZED MEDICINE

11.4.1 INSTRUMENTS

11.4.2 KITS

11.4.3 REAGENTS

11.5 AGRICULTURE AND ANIMAL RESEARCH

11.5.1 INSTRUMENTS

11.5.2 KITS

11.5.3 REAGENTS

11.6 OTHERS

12 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER

12.1 OVERVIEW

12.2 HOSPITALS AND DIAGNOSTIC CENTERS

12.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES

12.4 CONTRACT RESEARCH ORGANIZATIONS

12.5 CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO)

12.6 ACADEMIC/RESEARCH INSTITUTES

12.7 OTHERS

13 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION

13.1 EUROPE

13.1.1 GERMANY

13.1.2 U.K.

13.1.3 FRANCE

13.1.4 ITALY

13.1.5 SPAIN

13.1.6 SWITZERLAND

13.1.7 RUSSIA

13.1.8 TURKEY

13.1.9 BELGIUM

13.1.10 NETHERLANDS

13.1.11 DENMARK

13.1.12 POLAND

13.1.13 SWEDEN

13.1.14 NORWAY

13.1.15 FINLAND

13.1.16 REST OF EUROPE

14 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: EUROPE

15 SWOT ANALYSIS

16 COMPANY PROFILE

16.1 MERCK KGAA

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUE ANALYSIS

16.1.3 COMPANY SHARE ANALYSIS

16.1.4 PRODUCT PORTFOLIO

16.1.5 RECENT DEVELOPMENT

16.2 CYTIVA (DANAHER CORPORATION)

16.2.1 COMPANY SNAPSHOT

16.2.2 REVENUE ANALYSIS

16.2.3 COMPANY SHARE ANALYSIS

16.2.4 PRODUCT PORTFOLIO

16.2.5 RECENT DEVELOPMENTS

16.3 AGILENT TECHNOLOGIES, INC.

16.3.1 COMPANY SNAPSHOT

16.3.2 REVENUE ANALYSIS

16.3.3 COMPANY SHARE ANALYSIS

16.3.4 PRODUCT PORTFOLIO

16.3.5 RECENT DEVELOPMENT

16.4 BIO-RAD LABORATORIES, INC.

16.4.1 COMPANY SNAPSHOT

16.4.2 REVENUE ANALYSIS

16.4.3 COMPANY SHARE ANALYSIS

16.4.4 PRODUCT PORTFOLIO

16.4.5 RECENT DEVELOPMENT

16.5 F. HOFFMANN-LA ROCHE LTD

16.5.1 COMPANY SNAPSHOT

16.5.2 REVENUE ANALYSIS

16.5.3 COMPANY SHARE ANALYSIS

16.5.4 PRODUCT PORTFOLIO

16.5.5 RECENT DEVELOPMENT

16.6 ANALYTIK JENA GMBH+CO. KG

16.6.1 COMPANY SNAPSHOT

16.6.2 PRODUCT PORTFOLIO

16.6.3 RECENT DEVELOPMENT

16.7 AUTOGEN, INC.

16.7.1 COMPANY SNAPSHOT

16.7.2 PRODUCT PORTFOLIO

16.7.3 RECENT DEVELOPMENT

16.8 DAAN GENE CO., LTD.

16.8.1 COMPANY SNAPSHOT

16.8.2 PRODUCT PORTFOLIO

16.8.3 RECENT DEVELOPMENT

16.9 HIMEDIA LABORATORIES

16.9.1 COMPANY SNAPSHOT

16.9.2 PRODUCT PORTFOLIO

16.9.3 RECENT DEVELOPMENT

16.1 ILLUMINA, INC.

16.10.1 COMPANY SNAPSHOT

16.10.2 REVENUE ANALYSIS

16.10.3 PRODUCT PORTFOLIO

16.10.4 RECENT DEVELOPMENT

16.11 KURABO INDUSTRIES LTD.

16.11.1 COMPANY SNAPSHOT

16.11.2 REVENUE ANALYSIS

16.11.3 PRODUCT PORTFOLIO

16.11.4 RECENT DEVELOPMENT

16.12 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.

16.12.1 COMPANY SNAPSHOT

16.12.2 REVENUE ANALYSIS

16.12.3 PRODUCT PORTFOLIO

16.12.4 RECENT DEVELOPMENT

16.13 LGC BIOSEARCH TECHNOLOGIES

16.13.1 COMPANY SNAPSHOT

16.13.2 PRODUCT PORTFOLIO

16.13.3 RECENT DEVELOPMENTS

16.14 MACHEREY-NAGEL GMBH & CO. KG

16.14.1 COMPANY SNAPSHOT

16.14.2 PRODUCT PORTFOLIO

16.14.3 RECENT DEVELOPMENT

16.15 MAGGENOME TECHNOLOGIES PVT. LTD.

16.15.1 COMPANY SNAPSHOT

16.15.2 PRODUCT PORTFOLIO

16.15.3 RECENT DEVELOPMENT

16.16 MEDOX BIOTECH INDIA PVT. LTD.

16.16.1 COMPANY SNAPSHOT

16.16.2 PRODUCT PORTFOLIO

16.16.3 RECENT DEVELOPMENT

16.17 MERIDIAN BIOSCIENCE, INC.

16.17.1 COMPANY SNAPSHOT

16.17.2 PRODUCT PORTFOLIO

16.17.3 RECENT DEVELOPMENT

16.18 NEW ENGLAND BIOLABS

16.18.1 COMPANY SNAPSHOT

16.18.2 PRODUCT PORTFOLIO

16.18.3 RECENT DEVELOPMENT

16.19 NORGEN BIOTEK CORP.

16.19.1 COMPANY SNAPSHOT

16.19.2 PRODUCT PORTFOLIO

16.19.3 RECENT DEVELOPMENT

16.2 OMEGA BIO-TEK, INC.

16.20.1 COMPANY SNAPSHOT

16.20.2 PRODUCT PORTFOLIO

16.20.3 RECENT DEVELOPMENT

16.21 PCR BIOSYSTEMS

16.21.1 COMPANY SNAPSHOT

16.21.2 PRODUCT PORTFOLIO

16.21.3 RECENT DEVELOPMENT

16.22 PERKINELMER

16.22.1 COMPANY SNAPSHOT

16.22.2 REVENUE ANALYSIS

16.22.3 PRODUCT PORTFOLIO

16.22.4 RECENT DEVELOPMENT

16.23 PROMEGA CORPORATION

16.23.1 COMPANY SNAPSHOT

16.23.2 PRODUCT PORTFOLIO

16.23.3 RECENT DEVELOPMENT

16.24 QIAGEN

16.24.1 COMPANY SNAPSHOT

16.24.2 REVENUE ANALYSIS

16.24.3 PRODUCT PORTFOLIO

16.24.4 RECENT DEVELOPMENTS/NEWS

16.25 SAGE SCIENCE, INC.

16.25.1 COMPANY SNAPSHOT

16.25.2 PRODUCT PORTFOLIO

16.25.3 RECENT DEVELOPMENTS

16.26 TAKARA BIO INC.

16.26.1 COMPANY SNAPSHOT

16.26.2 REVENUE ANALYSIS

16.26.3 PRODUCT PORTFOLIO

16.26.4 RECENT DEVELOPMENTS

16.27 THERMO FISHER SCIENTIFIC INC.

16.27.1 COMPANY SNAPSHOT

16.27.2 REVENUE ANALYSIS

16.27.3 PRODUCT PORTFOLIO

16.27.4 RECENT DEVELOPMENT

16.28 TIANGEN BIOTECH (BEIJING) CO.,LTD.

16.28.1 COMPANY SNAPSHOT

16.28.2 PRODUCT PORTFOLIO

16.28.3 RECENT DEVELOPMENT

16.29 XI'AN TIANLONG SCIENCE AND TECHNOLOGY CO., LTD

16.29.1 COMPANY SNAPSHOT

16.29.2 PRODUCT PORTFOLIO

16.29.3 RECENT DEVELOPMENT

16.3 ZYMO RESEARCH CORPORATION

16.30.1 COMPANY SNAPSHOT

16.30.2 PRODUCT PORTFOLIO

16.30.3 RECENT DEVELOPMENT

17 QUESTIONNAIRE

18 RELATED REPORTS

List of Table

TABLE 1 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 2 EUROPE NEXT GENERATION SEQUENCING (NGS) IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 3 EUROPE GENOMIC DNA ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 4 EUROPE TOTAL RNA ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 5 EUROPE PCR CLEAN-UP IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 6 EUROPE PLASMID DNA ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 7 EUROPE MESSENGER RNA ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 8 EUROPE CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 9 EUROPE MICRORNA ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 10 EUROPE OTHERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 11 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 12 EUROPE INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 13 EUROPE INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 14 EUROPE INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 15 EUROPE INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 16 EUROPE INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)

TABLE 17 EUROPE INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)

TABLE 18 EUROPE KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 19 EUROPE KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 20 EUROPE DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 21 EUROPE MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 22 EUROPE MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 23 EUROPE MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 24 EUROPE COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 25 EUROPE COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 26 EUROPE COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 27 EUROPE RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 28 EUROPE MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 29 EUROPE MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 30 EUROPE MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 31 EUROPE COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 32 EUROPE COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 33 EUROPE COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 34 EUROPE VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 35 EUROPE VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 36 EUROPE VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 37 EUROPE REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 38 EUROPE REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 39 EUROPE REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 40 EUROPE REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 41 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)

TABLE 42 EUROPE FFPE SAMPLES IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 43 EUROPE BLOOD CELLS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 44 EUROPE BACTERIA, YEAST, AND PLANTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 45 EUROPE CELL-FREE SAMPLES IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 46 EUROPE CULTURED CELLS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 47 EUROPE MAMMALIAN CELLS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 48 EUROPE BRAIN AND KIDNEY TISSUE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 49 EUROPE OTHERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 50 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 51 EUROPE MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 52 EUROPE COLUMN-BASED ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 53 EUROPE REAGENT-BASED ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 54 EUROPE OTHERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 55 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 56 EUROPE DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 57 EUROPE DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 58 EUROPE DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 59 EUROPE DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 60 EUROPE PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 61 EUROPE PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 62 EUROPE AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 63 EUROPE AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 64 EUROPE OTHERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 65 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 66 EUROPE HOSPITALS AND DIAGNOSTIC CENTERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 67 EUROPE PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 68 EUROPE CONTRACT RESEARCH ORGANIZATIONS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 69 EUROPE CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO) IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 70 EUROPE ACADEMIC/RESEARCH INSTITUTES IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 71 EUROPE OTHERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 72 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 73 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 74 EUROPE INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 75 EUROPE INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 76 EUROPE INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 77 EUROPE INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)

TABLE 78 EUROPE INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)

TABLE 79 EUROPE KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 80 EUROPE DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 81 EUROPE MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 82 EUROPE MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 83 EUROPE MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 84 EUROPE COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 85 EUROPE COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 86 EUROPE COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 87 EUROPE RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 88 EUROPE MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 89 EUROPE MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 90 EUROPE MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 91 EUROPE COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 92 EUROPE COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 93 EUROPE COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 94 EUROPE VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 95 EUROPE VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 96 EUROPE VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 97 EUROPE REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 98 EUROPE REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 99 EUROPE REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 100 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 101 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 102 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 103 EUROPE DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 104 EUROPE DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 105 EUROPE PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 106 EUROPE AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 107 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)

TABLE 108 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 109 GERMANY NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 110 GERMANY INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 111 GERMANY INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 112 GERMANY INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 113 GERMANY INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)

TABLE 114 GERMANY INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)

TABLE 115 GERMANY KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 116 GERMANY DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 117 GERMANY MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 118 GERMANY MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 119 GERMANY MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 120 GERMANY COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 121 GERMANY COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 122 GERMANY COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 123 GERMANY RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 124 GERMANY MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 125 GERMANY MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 126 GERMANY MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 127 GERMANY COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 128 GERMANY COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 129 GERMANY COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 130 GERMANY VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 131 GERMANY VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 132 GERMANY VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (ASP)

TABLE 133 GERMANY REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 134 GERMANY REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 135 GERMANY REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 136 GERMANY NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 137 GERMANY NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 138 GERMANY NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 139 GERMANY DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 140 GERMANY DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 141 GERMANY PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 142 GERMANY AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 143 GERMANY NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)

TABLE 144 GERMANY NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 145 U.K. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 146 U.K. INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 147 U.K. INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 148 U.K. INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 149 U.K. INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)

TABLE 150 U.K. INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)

TABLE 151 U.K. KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 152 U.K. DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 153 U.K. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 154 U.K. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 155 U.K. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 156 U.K. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 157 U.K. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 158 U.K. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 159 U.K. RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 160 U.K. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 161 U.K. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 162 U.K. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 163 U.K. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 164 U.K. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 165 U.K. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 166 U.K. VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 167 U.K. VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 168 U.K. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 169 U.K. REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 170 U.K. REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 171 U.K. REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 172 U.K. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 173 U.K. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 174 U.K. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 175 U.K. DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 176 U.K. DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 177 U.K. PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 178 U.K. AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 179 U.K. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)

TABLE 180 U.K. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 181 FRANCE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 182 FRANCE INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 183 FRANCE INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 184 FRANCE INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 185 FRANCE INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)

TABLE 186 FRANCE INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)

TABLE 187 FRANCE KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 188 FRANCE DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 189 FRANCE MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 190 FRANCE MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 191 FRANCE MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 192 FRANCE COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 193 FRANCE COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 194 FRANCE COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 195 FRANCE RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 196 FRANCE MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 197 FRANCE MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 198 FRANCE MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 199 FRANCE COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 200 FRANCE COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 201 FRANCE COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 202 FRANCE VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 203 FRANCE VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 204 FRANCE VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (ASP)

TABLE 205 FRANCE REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 206 FRANCE REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 207 FRANCE REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 208 FRANCE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 209 FRANCE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 210 FRANCE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 211 FRANCE DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 212 FRANCE DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 213 FRANCE PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 214 FRANCE AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 215 FRANCE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)

TABLE 216 FRANCE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 217 ITALY NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 218 ITALY INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 219 ITALY INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 220 ITALY INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 221 ITALY INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)

TABLE 222 ITALY INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)

TABLE 223 ITALY KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 224 ITALY DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 225 ITALY MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 226 ITALY MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 227 ITALY MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 228 ITALY COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 229 ITALY COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 230 ITALY COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 231 ITALY RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 232 ITALY MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 233 ITALY MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 234 ITALY MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 235 ITALY COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 236 ITALY COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 237 ITALY COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 238 ITALY VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 239 ITALY VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 240 ITALY VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (ASP)

TABLE 241 ITALY REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 242 ITALY REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 243 ITALY REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 244 ITALY NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 245 ITALY NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 246 ITALY NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 247 ITALY DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 248 ITALY DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 249 ITALY PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 250 ITALY AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 251 ITALY NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)

TABLE 252 ITALY NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 253 SPAIN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 254 SPAIN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 255 SPAIN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 256 SPAIN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 257 SPAIN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)

TABLE 258 SPAIN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)

TABLE 259 SPAIN KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 260 SPAIN DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 261 SPAIN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 262 SPAIN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 263 SPAIN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 264 SPAIN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 265 SPAIN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 266 SPAIN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 267 SPAIN RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 268 SPAIN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 269 SPAIN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 270 SPAIN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 271 SPAIN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 272 SPAIN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 273 SPAIN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 274 SPAIN VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 275 SPAIN VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 276 SPAIN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 277 SPAIN REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 278 SPAIN REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 279 SPAIN REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 280 SPAIN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 281 SPAIN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 282 SPAIN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 283 SPAIN DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 284 SPAIN DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 285 SPAIN PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 286 SPAIN AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 287 SPAIN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)

TABLE 288 SPAIN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 289 SWITZERLAND NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 290 SWITZERLAND INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 291 SWITZERLAND INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 292 SWITZERLAND INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 293 SWITZERLAND INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)

TABLE 294 SWITZERLAND INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)

TABLE 295 SWITZERLAND KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 296 SWITZERLAND DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 297 SWITZERLAND MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 298 SWITZERLAND MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 299 SWITZERLAND MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 300 SWITZERLAND COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 301 SWITZERLAND COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 302 SWITZERLAND COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 303 SWITZERLAND RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 304 SWITZERLAND MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 305 SWITZERLAND MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 306 SWITZERLAND MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 307 SWITZERLAND COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 308 SWITZERLAND COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 309 SWITZERLAND COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 310 SWITZERLAND VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 311 SWITZERLAND VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 312 SWITZERLAND VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (ASP)

TABLE 313 SWITZERLAND REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 314 SWITZERLAND REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 315 SWITZERLAND REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 316 SWITZERLAND NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 317 SWITZERLAND NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 318 SWITZERLAND NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 319 SWITZERLAND DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 320 SWITZERLAND DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 321 SWITZERLAND PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 322 SWITZERLAND AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 323 SWITZERLAND NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)

TABLE 324 SWITZERLAND NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 325 RUSSIA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 326 RUSSIA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 327 RUSSIA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 328 RUSSIA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 329 RUSSIA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)

TABLE 330 RUSSIA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)

TABLE 331 RUSSIA KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 332 RUSSIA DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 333 RUSSIA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 334 RUSSIA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 335 RUSSIA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 336 RUSSIA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 337 RUSSIA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 338 RUSSIA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 339 RUSSIA RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 340 RUSSIA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 341 RUSSIA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 342 RUSSIA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 343 RUSSIA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 344 RUSSIA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 345 RUSSIA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 346 RUSSIA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 347 RUSSIA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 348 RUSSIA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (ASP)

TABLE 349 RUSSIA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 350 RUSSIA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 351 RUSSIA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 352 RUSSIA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 353 RUSSIA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 354 RUSSIA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 355 RUSSIA DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 356 RUSSIA DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 357 RUSSIA PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 358 RUSSIA AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 359 RUSSIA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)

TABLE 360 RUSSIA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 361 TURKEY NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 362 TURKEY INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 363 TURKEY INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 364 TURKEY INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 365 TURKEY INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)

TABLE 366 TURKEY INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)

TABLE 367 TURKEY KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 368 TURKEY DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 369 TURKEY MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 370 TURKEY MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 371 TURKEY MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 372 TURKEY COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 373 TURKEY COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 374 TURKEY COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 375 TURKEY RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 376 TURKEY MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 377 TURKEY MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 378 TURKEY MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 379 TURKEY COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 380 TURKEY COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 381 TURKEY COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 382 TURKEY VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 383 TURKEY VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 384 TURKEY VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (ASP)

TABLE 385 TURKEY REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 386 TURKEY REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 387 TURKEY REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 388 TURKEY NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 389 TURKEY NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 390 TURKEY NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 391 TURKEY DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 392 TURKEY DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 393 TURKEY PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 394 TURKEY AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 395 TURKEY NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)

TABLE 396 TURKEY NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 397 BELGIUM NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 398 BELGIUM INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 399 BELGIUM INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 400 BELGIUM INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 401 BELGIUM INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)

TABLE 402 BELGIUM INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)

TABLE 403 BELGIUM KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 404 BELGIUM DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 405 BELGIUM MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 406 BELGIUM MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 407 BELGIUM MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 408 BELGIUM COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 409 BELGIUM COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 410 BELGIUM COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 411 BELGIUM RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 412 BELGIUM MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 413 BELGIUM MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 414 BELGIUM MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 415 BELGIUM COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 416 BELGIUM COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 417 BELGIUM COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 418 BELGIUM VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 419 BELGIUM VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 420 BELGIUM VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (ASP)

TABLE 421 BELGIUM REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 422 BELGIUM REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 423 BELGIUM REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 424 BELGIUM NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 425 BELGIUM NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 426 BELGIUM NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 427 BELGIUM DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 428 BELGIUM DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 429 BELGIUM PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 430 BELGIUM AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 431 BELGIUM NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)

TABLE 432 BELGIUM NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 433 NETHERLANDS NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 434 NETHERLANDS INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 435 NETHERLANDS INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 436 NETHERLANDS INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 437 NETHERLANDS INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)

TABLE 438 NETHERLANDS INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)

TABLE 439 NETHERLANDS KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 440 NETHERLANDS DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 441 NETHERLANDS MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 442 NETHERLANDS MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 443 NETHERLANDS MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 444 NETHERLANDS COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 445 NETHERLANDS COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 446 NETHERLANDS COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 447 NETHERLANDS RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 448 NETHERLANDS MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 449 NETHERLANDS MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 450 NETHERLANDS MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 451 NETHERLANDS COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 452 NETHERLANDS COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 453 NETHERLANDS COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 454 NETHERLANDS VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 455 NETHERLANDS VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 456 NETHERLANDS VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (ASP)

TABLE 457 NETHERLANDS REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 458 NETHERLANDS REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 459 NETHERLANDS REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 460 NETHERLANDS NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 461 NETHERLANDS NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 462 NETHERLANDS NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 463 NETHERLANDS DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 464 NETHERLANDS DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 465 NETHERLANDS PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 466 NETHERLANDS AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 467 NETHERLANDS NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)

TABLE 468 NETHERLANDS NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 469 DENMARK NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 470 DENMARK INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 471 DENMARK INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 472 DENMARK INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 473 DENMARK INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)

TABLE 474 DENMARK INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)

TABLE 475 DENMARK KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 476 DENMARK DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 477 DENMARK MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 478 DENMARK MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 479 DENMARK MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 480 DENMARK COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 481 DENMARK COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 482 DENMARK COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 483 DENMARK RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 484 DENMARK MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 485 DENMARK MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 486 DENMARK MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 487 DENMARK COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 488 DENMARK COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 489 DENMARK COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 490 DENMARK VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 491 DENMARK VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 492 DENMARK VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (ASP)

TABLE 493 DENMARK REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 494 DENMARK REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 495 DENMARK REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 496 DENMARK NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 497 DENMARK NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 498 DENMARK NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 499 DENMARK DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 500 DENMARK DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 501 DENMARK PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 502 DENMARK AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 503 DENMARK NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)

TABLE 504 DENMARK NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 505 POLAND NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 506 POLAND INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 507 POLAND INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 508 POLAND INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 509 POLAND INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)

TABLE 510 POLAND INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)

TABLE 511 POLAND KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 512 POLAND DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 513 POLAND MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 514 POLAND MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 515 POLAND MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 516 POLAND COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 517 POLAND COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 518 POLAND COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 519 POLAND RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 520 POLAND MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 521 POLAND MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 522 POLAND MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 523 POLAND COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 524 POLAND COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 525 POLAND COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 526 POLAND VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 527 POLAND VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 528 POLAND VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (ASP)

TABLE 529 POLAND REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 530 POLAND REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 531 POLAND REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 532 POLAND NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 533 POLAND NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 534 POLAND NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 535 POLAND DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 536 POLAND DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 537 POLAND PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 538 POLAND AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 539 POLAND NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)

TABLE 540 POLAND NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 541 SWEDEN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 542 SWEDEN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 543 SWEDEN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 544 SWEDEN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 545 SWEDEN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)

TABLE 546 SWEDEN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)

TABLE 547 SWEDEN KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 548 SWEDEN DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 549 SWEDEN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 550 SWEDEN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 551 SWEDEN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 552 SWEDEN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 553 SWEDEN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 554 SWEDEN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 555 SWEDEN RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 556 SWEDEN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 557 SWEDEN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 558 SWEDEN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 559 SWEDEN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 560 SWEDEN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 561 SWEDEN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 562 SWEDEN VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 563 SWEDEN VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 564 SWEDEN VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (ASP)

TABLE 565 SWEDEN REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 566 SWEDEN REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 567 SWEDEN REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 568 SWEDEN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 569 SWEDEN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 570 SWEDEN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 571 SWEDEN DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 572 SWEDEN DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 573 SWEDEN PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 574 SWEDEN AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 575 SWEDEN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)

TABLE 576 SWEDEN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 577 NORWAY NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 578 NORWAY INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 579 NORWAY INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 580 NORWAY INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 581 NORWAY INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)

TABLE 582 NORWAY INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)

TABLE 583 NORWAY KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 584 NORWAY DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 585 NORWAY MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 586 NORWAY MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 587 NORWAY MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 588 NORWAY COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 589 NORWAY COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 590 NORWAY COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 591 NORWAY RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 592 NORWAY MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 593 NORWAY MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 594 NORWAY MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 595 NORWAY COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 596 NORWAY COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 597 NORWAY COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 598 NORWAY VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 599 NORWAY VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 600 NORWAY VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (ASP)

TABLE 601 NORWAY REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 602 NORWAY REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 603 NORWAY REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 604 NORWAY NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 605 NORWAY NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 606 NORWAY NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 607 NORWAY DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 608 NORWAY DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 609 NORWAY PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 610 NORWAY AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 611 NORWAY NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)

TABLE 612 NORWAY NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 613 FINLAND NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 614 FINLAND INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 615 FINLAND INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 616 FINLAND INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 617 FINLAND INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)

TABLE 618 FINLAND INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)

TABLE 619 FINLAND KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 620 FINLAND DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 621 FINLAND MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 622 FINLAND MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 623 FINLAND MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 624 FINLAND COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 625 FINLAND COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 626 FINLAND COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 627 FINLAND RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 628 FINLAND MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 629 FINLAND MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 630 FINLAND MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 631 FINLAND COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 632 FINLAND COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 633 FINLAND COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 634 FINLAND VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 635 FINLAND VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 636 FINLAND VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (ASP)

TABLE 637 FINLAND REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 638 FINLAND REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)

TABLE 639 FINLAND REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)

TABLE 640 FINLAND NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)

TABLE 641 FINLAND NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 642 FINLAND NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 643 FINLAND DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 644 FINLAND DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 645 FINLAND PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 646 FINLAND AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 647 FINLAND NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)

TABLE 648 FINLAND NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 649 REST OF EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

List of Figure

FIGURE 1 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: SEGMENTATION

FIGURE 2 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DROC ANALYSIS

FIGURE 4 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: EUROPE VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: MULTIVARIATE MODELLING

FIGURE 7 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: MARKET END USER COVERAGE GRID

FIGURE 11 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: SEGMENTATION

FIGURE 12 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: EXECUTIVE SUMMARY

FIGURE 13 STRATEGIC DECISIONS

FIGURE 14 LINE CHART, BY PRODUCT (2024)

FIGURE 15 THREE SEGMENTS COMPRISE THE EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT (2024)

FIGURE 16 NORTH AMERICA IS EXPECTED TO DOMINATE THE EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2025 TO 2032

FIGURE 17 INCREASING PREVALENCE OF GENETIC DISORDERS IS EXPECTED TO DRIVE THE EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET IN THE FORECAST PERIOD (2025-2032)

FIGURE 18 INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET IN 2025 & 2032

FIGURE 19 ASIA-PACIFIC IS THE FASTEST GROWING MARKET FOR THE EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET IN 2025 & 2032

FIGURE 20 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET

FIGURE 21 DISTRIBUTION OF REPORTED GENETIC CONDITIONS AMONG CHILDREN BY AGE GROUP (AGES 0–17)

FIGURE 22 DISTRIBUTION OF REPORTED GENETIC CONDITIONS AMONG CHILDREN BY GENDER

FIGURE 23 DISTRIBUTION OF REPORTED GENETIC CONDITIONS AMONG CHILDREN BY RACE AND ETHNICITY

FIGURE 24 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE, 2024

FIGURE 25 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE, 2025-2032 (USD THOUSAND)

FIGURE 26 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE, CAGR (2025-2032)

FIGURE 27 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE, LIFELINE CURVE

FIGURE 28 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY PRODUCT, 2024

FIGURE 29 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY PRODUCT, 2025-2032 (USD THOUSAND)

FIGURE 30 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY PRODUCT, CAGR (2025-2032)

FIGURE 31 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 32 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY SAMPLE TYPE, 2024

FIGURE 33 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY SAMPLE TYPE, 2025-2032 (USD THOUSAND)

FIGURE 34 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY SAMPLE TYPE, CAGR (2025-2032)

FIGURE 35 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY SAMPLE TYPE, LIFELINE CURVE

FIGURE 36 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY METHOD, 2024

FIGURE 37 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY METHOD, 2025-2032 (USD THOUSAND)

FIGURE 38 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY METHOD, CAGR (2025-2032)

FIGURE 39 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY METHOD, LIFELINE CURVE

FIGURE 40 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY APPLICATION, 2024

FIGURE 41 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY APPLICATION, 2025-2032 (USD THOUSAND)

FIGURE 42 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY APPLICATION, CAGR (2025-2032)

FIGURE 43 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 44 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY END USER, 2024

FIGURE 45 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY END USER, 2025-2032 (USD THOUSAND)

FIGURE 46 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY END USER, CAGR (2025-2032)

FIGURE 47 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY END USER, LIFELINE CURVE

FIGURE 48 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: SNAPSHOT (2024)

FIGURE 49 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY SHARE 2024 (%)

FIGURE 50 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY SHARE 2024 (%)

FIGURE 51 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY SHARE 2024 (%)

FIGURE 52 ASIA-PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY SHARE 2024 (%)

View Detailed Information Right Arrow

منهجية البحث

يتم جمع البيانات وتحليل سنة الأساس باستخدام وحدات جمع البيانات ذات أحجام العينات الكبيرة. تتضمن المرحلة الحصول على معلومات السوق أو البيانات ذات الصلة من خلال مصادر واستراتيجيات مختلفة. تتضمن فحص وتخطيط جميع البيانات المكتسبة من الماضي مسبقًا. كما تتضمن فحص التناقضات في المعلومات التي شوهدت عبر مصادر المعلومات المختلفة. يتم تحليل بيانات السوق وتقديرها باستخدام نماذج إحصائية ومتماسكة للسوق. كما أن تحليل حصة السوق وتحليل الاتجاهات الرئيسية هي عوامل النجاح الرئيسية في تقرير السوق. لمعرفة المزيد، يرجى طلب مكالمة محلل أو إرسال استفسارك.

منهجية البحث الرئيسية التي يستخدمها فريق بحث DBMR هي التثليث البيانات والتي تتضمن استخراج البيانات وتحليل تأثير متغيرات البيانات على السوق والتحقق الأولي (من قبل خبراء الصناعة). تتضمن نماذج البيانات شبكة تحديد موقف البائعين، وتحليل خط زمني للسوق، ونظرة عامة على السوق ودليل، وشبكة تحديد موقف الشركة، وتحليل براءات الاختراع، وتحليل التسعير، وتحليل حصة الشركة في السوق، ومعايير القياس، وتحليل حصة البائعين على المستوى العالمي مقابل الإقليمي. لمعرفة المزيد عن منهجية البحث، أرسل استفسارًا للتحدث إلى خبراء الصناعة لدينا.

التخصيص متاح

تعد Data Bridge Market Research رائدة في مجال البحوث التكوينية المتقدمة. ونحن نفخر بخدمة عملائنا الحاليين والجدد بالبيانات والتحليلات التي تتطابق مع هدفهم. ويمكن تخصيص التقرير ليشمل تحليل اتجاه الأسعار للعلامات التجارية المستهدفة وفهم السوق في بلدان إضافية (اطلب قائمة البلدان)، وبيانات نتائج التجارب السريرية، ومراجعة الأدبيات، وتحليل السوق المجدد وقاعدة المنتج. ويمكن تحليل تحليل السوق للمنافسين المستهدفين من التحليل القائم على التكنولوجيا إلى استراتيجيات محفظة السوق. ويمكننا إضافة عدد كبير من المنافسين الذين تحتاج إلى بيانات عنهم بالتنسيق وأسلوب البيانات الذي تبحث عنه. ويمكن لفريق المحللين لدينا أيضًا تزويدك بالبيانات في ملفات Excel الخام أو جداول البيانات المحورية (كتاب الحقائق) أو مساعدتك في إنشاء عروض تقديمية من مجموعات البيانات المتوفرة في التقرير.

Frequently Asked Questions

يتم تقسيم السوق بناءً على سوق عزل وتنقية الأحماض النووية في أوروبا، حسب المنتج (الأجهزة، والمجموعات، والكواشف)، والطريقة (العزل والتنقية باستخدام الخرز المغناطيسي، والعزل والتنقية باستخدام الأعمدة، والعزل والتنقية باستخدام الكواشف، وغيرها)، والنوع (تسلسل الجيل التالي (NGS)، وعزل وتنقية الحمض النووي الجينومي، وعزل وتنقية الحمض النووي الريبي الكلي، وتنظيف تفاعل البوليميراز المتسلسل (PCR)، وعزل وتنقية الحمض النووي البلازميدي، وعزل وتنقية الحمض النووي الريبي الرسول، وعزل وتنقية الأحماض النووية المتداولة، وعزل وتنقية الحمض النووي الريبي الدقيق، وغيرها)، والتطبيق (التشخيص، واكتشاف وتطوير الأدوية، والطب الشخصي، وأبحاث الزراعة والحيوان، وغيرها)، ونوع العينة (عينات FFPE، وخلايا الدم، والبكتيريا، والخميرة، والنباتات، والعينات الخالية من الخلايا، والخلايا المزروعة، وخلايا الثدييات، وأنسجة الدماغ والكلى، وغيرها). المستخدم النهائي (المستشفيات ومراكز التشخيص، وشركات الأدوية والتكنولوجيا الحيوية، ومنظمات البحوث التعاقدية، ومنظمات تطوير وتصنيع العقود (CDMO)، والمعاهد الأكاديمية/البحثية، وغيرها) - اتجاهات الصناعة وتوقعاتها حتى عام 2032 .
تم تقييم حجم تقرير تحليل حجم وحصة واتجاهات سوق بمبلغ 1.67 USD Billion دولارًا أمريكيًا في عام 2024.
من المتوقع أن ينمو تقرير تحليل حجم وحصة واتجاهات سوق بمعدل نمو سنوي مركب قدره 9.6% خلال فترة التوقعات من 2025 إلى 2032.
تشمل الشركات الكبرى العاملة في السوق Thermo Fisher Scientific Inc., Illumina Inc., PerkinElmer, Meridian Bioscience Inc., QIAGEN.
Testimonial